The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding

K De Vreese; D. Reymen; Philip Griffin; Alexander Steinkasserer; Gudrun Werner; Gary Bridger; José A. Esté; William James; Geoffrey Henson; Jan Desmyter; Jozef Anné; De Clercq Erik

doi:10.1016/0166-3542(95)00837-3

Related publications

Article1996

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

K De Vreese, V Kofler-Mongold, C Leutgeb, Volker Rudat, Kurt Vermeire, Sabine Schacht, Jozef Anné, De Clercq Erik, R. Datema, Gudrun Werner

Article1996

Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry

Françoise Soler, Christèle Poujade, Michel Evers, Jean‐Christophe Carry, Yvette Hénin, Anne Bousseau, Thierry Huet, Rudi Pauwels, De Clercq Erik, Jean-François Mayaux, Jean‐Bernard Le Pecq, Norbert Dereu

Article1996

ChemInform Abstract: Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry.

Françoise Soler, Christèle Poujade, M. Evers, J.‐C. CARRY, Yvette Hénin, Anne Bousseau, Thierry Huet, Rudi Pauwels, De Clercq Erik, J F Mayaux, Jean Bernard Le Pecq, Norbert Dereu

Article1992

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

De Clercq Erik, Naoki Yamamoto, Rudi Pauwels, Masanori Baba, Dominique Schols, Hiroshi Nakashima, Jan Balzarini, Zeger Debyser, Barry A. Murrer, David H. Schwartz

Article1992

Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors

Prem Mohan, Dominique Schols, Masanori Baba, De Clercq Erik

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding

Discussion(0)

Related publications

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry

ChemInform Abstract: Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry.

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors